सामग्री पर जाएँ

दवाओं की अंतःक्रिया

Blinatumomab + Siponimod

गंभीरता: मध्यम

Blinatumomab and Siponimod: moderate interaction.

अंतिम अपडेट

केवल स्वास्थ्य पेशेवरों के लिए — मात्र संदर्भ हेतु। यह पृष्ठ संक्षिप्त सारांश है, चिकित्सकीय सलाह नहीं है और आधिकारिक लेबल या नैदानिक निर्णय का विकल्प नहीं है। दवा लिखने या देने से पहले हमेशा जाँच करें।

इस पृष्ठ की नैदानिक सामग्री केवल अंग्रेज़ी में उपलब्ध है।

सारांश

Blinatumomab engages T cells against CD19-positive B cells and causes B-cell depletion, cytopenias and infections. Combining it with siponimod, which reduces circulating lymphocytes, may add to infection risk and may blunt T-cell redirected activity.

इस इंटरैक्शन का सरल भाषा में अर्थ

Blinatumomab and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Blinatumomab belongs to Oncology; Siponimod belongs to Central Nervous System.

साक्ष्य स्तर: Low

ऐसा क्यों होता है

Additive immune suppression from B-cell depletion and S1P-mediated lymphocyte sequestration.

क्या करें

Monitor for infection and check blood counts regularly. Siponimod usually should be held during blinatumomab treatment, so decide this with the oncology and neurology teams.

फार्मासिस्ट से क्या पूछें

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ सदस्यों के लिए

पूरा पेज खोलें

Blinatumomab और Siponimod की पूरी प्रबंधन सलाह, अतिरिक्त नोट्स, साक्ष्य का विवरण और पूरे पर्चे का इंटरैक्शन चेकर खोलने के लिए खाता बनाएँ और Pro+ ट्रायल शुरू करें।

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

वेब पर Pro+ को 14 दिन मुफ़्त आज़माएँ। कार्ड की ज़रूरत नहीं।

अक्सर पूछे जाने वाले प्रश्न

Can I take Blinatumomab with Siponimod?

MediHelp rates the interaction as moderate. Blinatumomab and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Blinatumomab engages T cells against CD19-positive B cells and causes B-cell depletion, cytopenias and infections. Combining it with siponimod, which reduces circulating lymphocytes, may add to infection risk and may blunt T-cell redirected activity.

How serious is the interaction between Blinatumomab and Siponimod?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for infection and check blood counts regularly. Siponimod usually should be held during blinatumomab treatment, so decide this with the oncology and neurology teams.

What other medicines interact with Siponimod?

MediHelp also lists interactions of Siponimod with, for example, Cladribine, Fingolimod, Fluconazole. The full list is on the Siponimod page.

MediHelp ऐप में पूर्ण मोनोग्राफ़, खुराक और इंटरैक्शन चेकर

MediHelp ऐप में पूरा संदर्भ खोलें, कई दवाओं की अंतःक्रियाएँ जाँचें और खुराक टूल इस्तेमाल करें।

A–Z ब्राउज़ करें · दवाओं की अंतःक्रिया

ऐप पाएँ साइन इन